Histopathology of Parotid Pleomorphic Adenomas: A "Pleomorphic Approach" to a Demanding Lesion.


Journal

The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378

Informations de publication

Date de publication:
01 2022
Historique:
revised: 14 06 2021
received: 10 05 2021
accepted: 24 06 2021
pubmed: 3 7 2021
medline: 15 2 2022
entrez: 2 7 2021
Statut: ppublish

Résumé

The aim of this study was to identify potential associations between epidemiologic, morphologic, and histopathologic features in pleomorphic adenomas (PAs) of the parotid gland in order to extract information about the natural course and biologic behavior of these lesions on the basis of a single-center series of 845 cases within a period of 15 years. Retrospective study in a tertiary academic center. For this study, an experienced head and neck pathologist critically re-evaluated the histological slides of the pathological specimens of all patients who underwent a parotidectomy for PA of the parotid gland between 2006 and 2020. A total of 845 cases made up our study sample. Our analysis showed a statistically significant association of the histologic subtype with younger age (P = .001) and maximal diameter (P = .044), with the hypocellular type being encountered more often in younger patients and in smaller lesions. The same subtype was significantly associated with an incomplete capsule (P = .001), pseudopodia (P = .006), and satellite nodules (P = .001). An incomplete capsule was associated with the presence of pseudopodia (P = .001) and satellite nodules (P = .001). It seems that various histologic subtypes have different capsule-producing properties. Apparently, over the course of time, tumor material builds a finger-like projection still inside the capsule, separates itself from the parenchyma with fibrous tissue still remaining enclosed within the capsule (pseudopodium), slowly penetrates the capsule (incomplete capsule), and leaves the main lesion taking a part of the capsule with it (satellite nodules). Laryngoscope, 132:73-77, 2022.

Identifiants

pubmed: 34213780
doi: 10.1002/lary.29726
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-77

Informations de copyright

© 2021 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc.

Références

Mantsopoulos K, Iro AK, Sievert M, et al. Refinement of the surgical indication and increasing expertise are associated with a better quality of pathology specimen in pleomorphic adenomas. Acta Otolaryngol 2021;141:414-418. https://doi.org/10.1080/00016489.2021.1871947.
Iro AK, Agaimy A, Muller SK, Sievert M, Iro H, Mantsopoulos K. Satellite nodules in pleomorphic adenomas of the parotid gland: a nightmare for less invasive parotid surgery? Oral Oncol Apr 2021;115:105218. https://doi.org/10.1016/j.oraloncology.2021.105218.
Witt RL, Eisele DW, Morton RP, Nicolai P, Poorten VV, Zbaren P. Etiology and management of recurrent parotid pleomorphic adenoma. Laryngoscope 2015;125:888-893. https://doi.org/10.1002/lary.24964.
Mantsopoulos K, Iro AK, Sievert M, et al. Is extracapsular dissection for pleomorphic adenoma rather a euphemism for enucleation jeopardising the intactness of the capsule? Br J Oral Maxillofac Surg 2021. https://doi.org/10.1016/j.bjoms.2021.03.002.
Mantsopoulos K, Scherl C, Iro H. Investigation of arguments against properly indicated extracapsular dissection in the parotid gland. Head Neck 2017;39:498-502. https://doi.org/10.1002/hed.24629.
Guntinas-Lichius O, Klussmann JP, Wittekindt C, Stennert E. Parotidectomy for benign parotid disease at a university teaching hospital: outcome of 963 operations. Laryngoscope 2006;116:534-540. https://doi.org/10.1097/01.mlg.0000200741.37460.ea.
Bar B, Mantsopoulos K, Iro H. Paradigm shift in surgery for benign parotid tumors: 19 years of experience with almost 3000 cases. Laryngoscope 2020;130:1941-1946. https://doi.org/10.1002/lary.28454.
Seifert G, Langrock I, Donath K. A pathological classification of pleomorphic adenoma of the salivary glands (author's transl). HNO 1976;24:415-426. Pathomorphologische Subklassifikation der pleomorphen Speicheldrusenadenome. Analyse von 310 pleomorphen Parotisadenomen.
Zbaren P, Stauffer E. Pleomorphic adenoma of the parotid gland: histopathologic analysis of the capsular characteristics of 218 tumors. Head Neck 2007;29:751-757. https://doi.org/10.1002/hed.20569.
Toole BP. Glycosaminoglycans in Morphogenesis. In: Hay ED. (eds) Cell Biology of Extracellular Matrix. Springer, Boston, MA: 1981. p. 259-294.
Zbaren P, Tschumi I, Nuyens M, Stauffer E. Recurrent pleomorphic adenoma of the parotid gland. Am J Surg 2005;189:203-207. https://doi.org/10.1016/j.amjsurg.2004.11.008.
Stennert E, Wittekindt C, Klussmann JP, Arnold G, Guntinas-Lichius O. Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study. Laryngoscope 2004;114:158-163. https://doi.org/10.1097/00005537-200401000-00030.
Wittekindt C, Streubel K, Arnold G, Stennert E, Guntinas-Lichius O. Recurrent pleomorphic adenoma of the parotid gland: analysis of 108 consecutive patients. Head Neck 2007;29:822-828. https://doi.org/10.1002/hed.20613.
Laccourreye H, Laccourreye O, Cauchois R, Jouffre V, Menard M, Brasnu D. Total conservative parotidectomy for primary benign pleomorphic adenoma of the parotid gland: a 25-year experience with 229 patients. Laryngoscope 1994;104:1487-1494. https://doi.org/10.1288/00005537-199412000-00011.
Harrison JD, Auger DW. Mucosubstance histochemistry of pleomorphic adenoma of parotid and submandibular salivary glands of man: light and electron microscopy. Histochem J 1991;23:293-302. https://doi.org/10.1007/BF01044960.
Stennert E, Guntinas-Lichius O, Klussmann JP, Arnold G. Histopathology of pleomorphic adenoma in the parotid gland: a prospective unselected series of 100 cases. Laryngoscope 2001;111:2195-2200. https://doi.org/10.1097/00005537-200112000-00024.
Naeim F, Forsberg MI, Waisman J, Coulson WF. Mixed tumors of the salivary glands. Growth pattern and recurrence. Arch Pathol Lab Med 1976;100:271-275.
Nakayama H, Naruse K, Miyazaki E, et al. The specific distribution of dendritic interstitial cells at the tumor border of major salivary gland pleomorphic adenomas. Mod Pathol 1999;12:445-449.
Cotran RS, Kumar V, Collins T. Neoplasia. In: Cotran RS, Kumar V, Collins T, eds. Robbins' Pathologic Basis of Disease. 6th ed. Philadelphia: Saunders; 1998.
Evans RW, Cruickshanks AH. Epithelial Tumours of the Salivary Glands. Philadelphia: Saunders; 1970.
van Egmond SL, de Leng WW, Morsink FH, Offerhaus GJ, Brosens LA. Monoclonal origin of primary unilateral multifocal pleomorphic adenoma of the parotid gland. Hum Pathol 2013;44:923-926. https://doi.org/10.1016/j.humpath.2012.10.008.
Miliauskas JR, Hunt JL. Primary unilateral multifocal pleomorphic adenoma of the parotid gland: molecular assessment and literature review. Head Neck Pathol 2008;2:339-342. https://doi.org/10.1007/s12105-008-0081-2.

Auteurs

Konstantinos Mantsopoulos (K)

Department of Otorhinolaryngology, Head and Neck Surgery, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.

Vivian Thimsen (V)

Department of Otorhinolaryngology, Head and Neck Surgery, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.

Antoniu-Oreste Gostian (AO)

Department of Otorhinolaryngology, Head and Neck Surgery, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.

Sarina K Müller (SK)

Department of Otorhinolaryngology, Head and Neck Surgery, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.

Matti Sievert (M)

Department of Otorhinolaryngology, Head and Neck Surgery, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.

Ann-Kristin Iro (AK)

Department of Otorhinolaryngology, Head and Neck Surgery, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.

Abbas Agaimy (A)

Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.

Heinrich Iro (H)

Department of Otorhinolaryngology, Head and Neck Surgery, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH